ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $33,364,000 | -5.8% | 2,682,017 | +3.6% | 1.90% | -7.5% |
| Q3 2016 | $35,424,000 | +89.1% | 2,587,617 | +2.1% | 2.06% | +45.4% |
| Q2 2016 | $18,735,000 | +30.4% | 2,535,117 | +12.8% | 1.42% | +26.9% |
| Q1 2016 | $14,367,000 | +1.8% | 2,248,317 | -0.4% | 1.12% | +42.0% |
| Q4 2015 | $14,108,000 | +8.2% | 2,257,217 | +1.1% | 0.78% | +25.2% |
| Q3 2015 | $13,033,000 | -29.4% | 2,231,717 | 0.0% | 0.63% | -23.6% |
| Q2 2015 | $18,456,000 | +0.4% | 2,231,717 | 0.0% | 0.82% | -9.7% |
| Q1 2015 | $18,389,000 | +19.9% | 2,231,717 | 0.0% | 0.91% | +1.0% |
| Q4 2014 | $15,332,000 | +27.2% | 2,231,717 | 0.0% | 0.90% | 0.0% |
| Q3 2014 | $12,051,000 | -16.9% | 2,231,717 | -1.9% | 0.90% | -16.6% |
| Q2 2014 | $14,496,000 | -74.0% | 2,275,603 | -67.1% | 1.08% | -53.2% |
| Q1 2014 | $55,754,000 | +137.6% | 6,917,248 | +101.0% | 2.30% | +5.3% |
| Q4 2013 | $23,470,000 | – | 3,441,324 | – | 2.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,000,000 | $96,720,000 | 33.30% |
| Opaleye Management Inc. | 1,670,000 | $13,460,000 | 9.94% |
| Slate Path Capital LP | 6,620,000 | $53,357,000 | 4.04% |
| Granite Point Capital Management, L.P. | 648,000 | $5,223,000 | 3.74% |
| Palo Alto Investors LP | 6,917,248 | $55,754,000 | 2.30% |
| Camber Capital Management LP | 3,000,000 | $24,180,000 | 1.90% |
| Geduld E E | 277,600 | $2,237,000 | 1.21% |
| Elk Creek Partners, LLC | 290,886 | $2,345,000 | 1.01% |
| SELZ CAPITAL LLC | 400,000 | $3,224,000 | 0.81% |
| GENERAL AMERICAN INVESTORS CO INC | 1,200,000 | $9,672,000 | 0.81% |